1. Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study
   Kosuke Sato et al, 2022, Medicine CrossRef
2. Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study
   Jun Inoue et al, 2022, Journal of Clinical Medicine CrossRef
3. A 28-year-old male patient with asymptomatic and multi-drug-resistant HBV infection: a case report
   Syed Ayaz Kazmi et al, 2024, Egyptian Liver Journal CrossRef
4. Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir
   Kosuke Sato et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef
5. Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
   Takashi Kumada et al, 2021, European Journal of Gastroenterology & Hepatology CrossRef